Clinical trial for Malaria Vaccine Study
The FMP013/FMP014 vaccines have been designed to prevent malaria caused by Plasmodium falciparum. This is the first time these vaccine will be tested in humans.
The FMP013/FMP014 vaccines have been designed to prevent malaria caused by Plasmodium falciparum. This is the first time these vaccine will be tested in humans.
This study involves one screening visit,1 in-house stay of 8 Days / 7 Nights
The WRAIR Clinical Trials Center is seeking healthy adults ages 18-55 with no previously documented Covid-19 infection to participate in a Specimen Collection Study. Participants
Healthy male and females aged 18-45. BMI 18-30. Long term… One-23 night stay & 1 phone call. Stipend $7,845.00
Healthy male and females aged 18-45. BMI 18-30. Long term… One-23 night stay & 1 phone call. Stipend $7,845.00
This investigational medication is being developed to treat Crohn’s Disease and Ulcerative Colitis One – 5 Night Stay & 7 Returns
This investigational medication is being developed to treat obesity 7 Visits (No Overnight Stays)
This investigational medication is being developed for patients with Cystic Fibrosis. Up to a 28 night stay and 1 follow up phone call
Are You Healthy, Non-Smoking and 18-50 Years Old? Study #476X. Up to $8,100 for Time and Travel For more information or to find out if
This investigational medication is being developed to treat Alzheimer’s disease, Parkinson’s disease and Multiple Sclerosis. One – 16 Night Stay & 1 Phone Call